A Curcumin‐Loaded Iron‐Porphyrin Covalent Organic Framework Alleviates Atherosclerosis by Modulating Oxidative Stress and Lipid Metabolism
Small · 2026-11 · 22 (63)
DOI: 10.1002/smll.76537 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 28.10.2026. Verfasst von Chengpeng Niu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases (Ministry of Education), Ganzhou Key Laboratory of Antibody…. Hauptthemen laut MEDLINE: Atherosclerosis, Curcumin, Oxidative Stress, Iron. Die Arbeit nennt 62 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangxi Province, Bureau of Science and Technology of Ganzhou Municipality, Ganzhou Soviet Area Talent Program.
Abstract (Originalsprache)
Atherosclerosis (AS) requires multi‐target therapies addressing lipid accumulation, oxidative stress, and inflammation, yet lipid‐lowering alone insufficiently mitigates residual cardiovascular risk. Curcumin (Cur), a natural polyphenol with well‐established anti‐atherosclerotic activities, is severely hampered by extremely low oral bioavailability and rapid metabolic clearance. To overcome these limitations, an iron porphyrin‐based covalent organic framework (COF), FeTAPP‐Dha, was prepared by condensing 5,10,15,20‐tetrakis‐(4‐aminophenyl)‐porphyrin‐Fe‐(III) chloride with 2,5‐dihydroxyterephthalaldehyde. Cur was then incorporated into the hydrophobic channels of FeTAPP‐Dha through hydrogen‐bond‐mediated size matching, producing FeTAPP‐Dha‐Cur with a loading efficiency of 12.5%. The incorporated iron porphyrin units provide reactive oxygen species scavenging capability, enabling sustained H 2 O 2 decomposition and intercepting oxidative stress at its source. Moreover, the acidic microenvironment characteristic of atherosclerotic plaques impairs hydrogen‐bonding interactions, facilitating on‐demand Cur release at lesion sites while minimizing systemic exposure. In ApoE −/− mice, FeTAPP‐Dha‐Cur effectively inhibited foam cell formation and significantly reduced aortic plaque burden. These effects were accompanied by activation of the AMP‐activated protein kinase–acetyl‐CoA carboxylase signaling axis and suppression of inflammation. Collectively, FeTAPP‐Dha‐Cur achieved superior therapeutic outcomes compared with free Cur or empty carrier. This work establishes a COF‐based synergistic platform that integrates carrier‐mediated microenvironment regulation with stimuli‐responsive drug delivery, offering a promising paradigm for multi‐target AS therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases (Ministry of Education), Ganzhou Key Laboratory of Antibody Drug and Precision Medicine, Gannan Medical University, Ganzhou, Chin…
- School of Basic Medicine, Gannan Medical University, Ganzhou, China.
- School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
ORCID-Profile: Chengpeng Niu, Shuyong Zhang
Förderung
- Natural Science Foundation of Jiangxi Province
- Bureau of Science and Technology of Ganzhou Municipality
- Ganzhou Soviet Area Talent Program
Zitieren
APA
Niu, C., Xia, Y., Chen, Z., Yu, S., Yu, H., Wang, F., Jiang, X., Liu, Y., & Zhang, S. (2026). A Curcumin‐Loaded Iron‐Porphyrin Covalent Organic Framework Alleviates Atherosclerosis by Modulating Oxidative Stress and Lipid Metabolism. Small, 22(63). https://doi.org/10.1002/smll.76537
Vancouver
Niu C, Xia Y, Chen Z, Yu S, Yu H, Wang F, et al. A Curcumin‐Loaded Iron‐Porphyrin Covalent Organic Framework Alleviates Atherosclerosis by Modulating Oxidative Stress and Lipid Metabolism. Small. 2026;22(63). doi:10.1002/smll.76537
BibTeX
@article{Niu2026,
author = {Niu, Chengpeng and Xia, Yujie and Chen, Zhiquan and Yu, Shanshan and Yu, Haojie and Wang, Feiqi and Jiang, Xinzheng and Liu, Yong'ai and Zhang, Shuyong},
title = {A Curcumin‐Loaded Iron‐Porphyrin Covalent Organic Framework Alleviates Atherosclerosis by Modulating Oxidative Stress and Lipid Metabolism},
journal = {Small},
year = {2026},
volume = {22},
number = {63},
doi = {10.1002/smll.76537}
}
EUVIMED